Chimeric Therapeutics Valuation
| CHMMF Stock | 0 0.00 0.00% |
Chimeric Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Chimeric Therapeutics from analyzing the firm fundamentals such as Shares Outstanding of 437.09 M, return on equity of -0.63, and Operating Margin of (5.57) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Chimeric Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Chimeric Therapeutics is based on 3 months time horizon. Increasing Chimeric Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Chimeric pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Chimeric Therapeutics Limited. Since Chimeric Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chimeric Pink Sheet. However, Chimeric Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 8.4E-4 | Hype 0.001 |
The real value of Chimeric Pink Sheet, also known as its intrinsic value, is the underlying worth of Chimeric Therapeutics Company, which is reflected in its stock price. It is based on Chimeric Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chimeric Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chimeric Therapeutics Limited helps investors to forecast how Chimeric pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chimeric Therapeutics more accurately as focusing exclusively on Chimeric Therapeutics' fundamentals will not take into account other important factors: About Chimeric Therapeutics Valuation
The pink sheet valuation mechanism determines Chimeric Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Chimeric Therapeutics. We calculate exposure to Chimeric Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chimeric Therapeutics's related companies.8 Steps to conduct Chimeric Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Chimeric Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Chimeric Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Chimeric Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Chimeric Therapeutics' revenue streams: Identify Chimeric Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Chimeric Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Chimeric Therapeutics' growth potential: Evaluate Chimeric Therapeutics' management, business model, and growth potential.
- Determine Chimeric Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Chimeric Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Chimeric Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Chimeric Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 425.3 M | |
| Retained Earnings | -30.9 M |
Complementary Tools for Chimeric Pink Sheet analysis
When running Chimeric Therapeutics' price analysis, check to measure Chimeric Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimeric Therapeutics is operating at the current time. Most of Chimeric Therapeutics' value examination focuses on studying past and present price action to predict the probability of Chimeric Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimeric Therapeutics' price. Additionally, you may evaluate how the addition of Chimeric Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |